Equities research analysts predict that HEXO Corp. (NYSE:HEXO) will post sales of $18.90 million for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have made estimates for HEXO’s earnings, with the lowest sales estimate coming in at $16.58 million and the highest estimate coming in at $22.05 million. HEXO reported sales of $11.79 million in the same quarter last year, which indicates a positive year over year growth rate of 60.3%. The business is expected to announce its next earnings report on Monday, October 26th.
On average, analysts expect that HEXO will report full year sales of $58.82 million for the current year, with estimates ranging from $56.78 million to $62.18 million. For the next fiscal year, analysts anticipate that the business will post sales of $105.62 million, with estimates ranging from $77.07 million to $137.25 million. Zacks Investment Research’s sales calculations are an average based on a survey of research firms that follow HEXO.
NYSE:HEXO traded up $0.01 during trading hours on Wednesday, reaching $0.66. The company had a trading volume of 2,949,809 shares, compared to its average volume of 10,363,553. The stock has a market capitalization of $318.59 million, a price-to-earnings ratio of -0.51 and a beta of 0.35. HEXO has a twelve month low of $0.35 and a twelve month high of $4.14.
HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. It offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. The company offers its adult-use and medical products under the HEXO brand name.
Featured Story: What are defining characteristics of a correction?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for HEXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HEXO and related companies with MarketBeat.com's FREE daily email newsletter.